TY - JOUR
T1 - Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population
T2 - A case-control study
AU - Bai, Yun
AU - Xu, Liang
AU - Yang, Xiaobo
AU - Hu, Zhibin
AU - Yuan, Jing
AU - Wang, Feng
AU - Shao, Minhua
AU - Yuan, Wentao
AU - Qian, Ji
AU - Ma, Hongxia
AU - Wang, Ying
AU - Liu, Hongliang
AU - Chen, Weihong
AU - Yang, Lin
AU - Jing, Guangfu
AU - Huo, Xiang
AU - Chen, Feng
AU - Liu, Yanhong
AU - Jin, Li
AU - Wei, Qingyi
AU - Huang, Wei
AU - Shen, Hongbing
AU - Lu, Daru
AU - Wu, Tangchun
PY - 2007/5/13
Y1 - 2007/5/13
N2 - Background: The nucleotide excision repair (NER) protein, xeroderma pigmentosum C (XPC), participates in recognizing DNA lesions and initiating DNA repair in response to DNA damage. Because mutations in XPC cause a high risk of cancer in XP patients, we hypothesized that inherited sequence variations in XPC may alter DNA repair and thus susceptibility to cancer. Methods: In this hospital-based case-control study, we investigated five XPC tagging, common single nucleotide polymorphisms (tagging SNPs) in 1,010 patients with newly diagnosed lung cancer and 1,011 matched cancer free controls in a Chinese population. Results: In individual tagging SNP analysis, we found that rs3731055AG+AA variant genotypes were associated with a significantly decreased risk of lung adenocarcinoma [adjusted odds ratio (OR), 0.71; 95% confidence interval (CI), 0.56-0.90] but an increased risk of small cell carcinomas [adjusted OR, 1.79; 95% CI, 1.05-3.07]. Furthermore, we found that haplotype ACCCA was associated with a decreased risk of lung adenocarcinoma [OR, 0.78; 95% CI, 0.62-0.97] but an increased risk of small cell carcinomas [OR, 1.68; 95% CI, 1.04-2.71], which reflected the presence of rs3731055A allele in this haplotype. Further stratified analysis revealed that the protective effect of rs3731055AG+AA on risk of lung adenocarcinoma was more evident among young subjects (age ≤ 60) and never smokers. Conclusion: These results suggest that inherited sequence variations in XPC may modulate risk of lung cancer, especially lung adenocarcinoma, in Chinese populations. However, these findings need to be verified in larger confirmatory studies with more comprehensively selected tagging SNPs.
AB - Background: The nucleotide excision repair (NER) protein, xeroderma pigmentosum C (XPC), participates in recognizing DNA lesions and initiating DNA repair in response to DNA damage. Because mutations in XPC cause a high risk of cancer in XP patients, we hypothesized that inherited sequence variations in XPC may alter DNA repair and thus susceptibility to cancer. Methods: In this hospital-based case-control study, we investigated five XPC tagging, common single nucleotide polymorphisms (tagging SNPs) in 1,010 patients with newly diagnosed lung cancer and 1,011 matched cancer free controls in a Chinese population. Results: In individual tagging SNP analysis, we found that rs3731055AG+AA variant genotypes were associated with a significantly decreased risk of lung adenocarcinoma [adjusted odds ratio (OR), 0.71; 95% confidence interval (CI), 0.56-0.90] but an increased risk of small cell carcinomas [adjusted OR, 1.79; 95% CI, 1.05-3.07]. Furthermore, we found that haplotype ACCCA was associated with a decreased risk of lung adenocarcinoma [OR, 0.78; 95% CI, 0.62-0.97] but an increased risk of small cell carcinomas [OR, 1.68; 95% CI, 1.04-2.71], which reflected the presence of rs3731055A allele in this haplotype. Further stratified analysis revealed that the protective effect of rs3731055AG+AA on risk of lung adenocarcinoma was more evident among young subjects (age ≤ 60) and never smokers. Conclusion: These results suggest that inherited sequence variations in XPC may modulate risk of lung cancer, especially lung adenocarcinoma, in Chinese populations. However, these findings need to be verified in larger confirmatory studies with more comprehensively selected tagging SNPs.
UR - http://www.scopus.com/inward/record.url?scp=34249887092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249887092&partnerID=8YFLogxK
U2 - 10.1186/1471-2407-7-81
DO - 10.1186/1471-2407-7-81
M3 - Article
C2 - 17498315
AN - SCOPUS:34249887092
SN - 1471-2407
VL - 7
JO - BMC cancer
JF - BMC cancer
M1 - 81
ER -